GlaxoSmithKline Pharmaceuticals Ownership
Who are the major shareholders and have insiders been buying or selling?
Recent Insider Transactions
Insider Trading Volume
Insider Buying: Insufficient data to determine if insiders have bought more shares than they have sold in the past 3 months.
Ownership Breakdown
Owner Type | Number of Shares | Ownership Percentage |
---|---|---|
Individual Insiders | 600 | 0.000354% |
State or Government | 985,957 | 0.582% |
Institutions | 17,682,151 | 10.4% |
General Public | 23,682,802 | 14% |
Public Companies | 127,054,524 | 75% |
Dilution of Shares: Shareholders have not been meaningfully diluted in the past year.
Top Shareholders
Ownership | Name | Shares | Current Value | Change % | Portfolio % | |
---|---|---|---|---|---|---|
127,054,524 | ₹271.0b | 0% | no data | |||
3,278,114 | ₹7.0b | -15.3% | 0.05% | |||
2,157,098 | ₹4.6b | -47.5% | 0.09% | |||
2,115,160 | ₹4.5b | 0% | 1.67% | |||
1,751,731 | ₹3.7b | 116% | 0.12% | |||
1,711,233 | ₹3.6b | -11.1% | 0.21% | |||
1,151,961 | ₹2.5b | 0% | no data | |||
1,111,796 | ₹2.4b | 0% | 0.1% | |||
985,907 | ₹2.1b | -0.06% | no data | |||
860,000 | ₹1.8b | 115% | 0.28% | |||
813,149 | ₹1.7b | 0% | 0.02% | |||
742,868 | ₹1.6b | 17.5% | no data | |||
406,574 | ₹867.1m | 0% | 0.33% | |||
285,930 | ₹609.8m | 535% | 0.12% | |||
209,725 | ₹447.3m | -23% | no data | |||
192,240 | ₹410.0m | 27.6% | no data | |||
159,781 | ₹340.8m | 166% | 0.71% | |||
146,200 | ₹311.8m | -16.2% | 0.18% | |||
100,000 | ₹213.3m | 0% | 0.11% | |||
70,282 | ₹149.9m | 32.4% | no data | |||
57,236 | ₹122.1m | 0% | no data | |||
42,965 | ₹91.6m | 26.5% | no data | |||
34,158 | ₹72.8m | 0% | no data | |||
33,937 | ₹72.4m | -56.8% | no data | |||
26,982 | ₹57.6m | 1.66% | 0.01% |